Globus Medical, Inc.
GMED · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $11,225,897 | $6,026,406 | $7,461,833 | $7,272,995 |
| - Cash | $784,438 | $467,292 | $150,466 | $193,069 |
| + Debt | $537,188 | $520,404 | $6,011 | $0 |
| Enterprise Value | $10,978,647 | $6,079,518 | $7,317,378 | $7,079,926 |
| Revenue | $2,519,355 | $1,568,476 | $1,022,843 | $958,102 |
| % Growth | 60.6% | 53.3% | 6.8% | – |
| Gross Profit | $1,483,876 | $1,020,302 | $759,118 | $718,879 |
| % Margin | 58.9% | 65.1% | 74.2% | 75% |
| EBITDA | $473,725 | $346,583 | $304,503 | $264,725 |
| % Margin | 18.8% | 22.1% | 29.8% | 27.6% |
| Net Income | $102,984 | $122,873 | $190,169 | $149,191 |
| % Margin | 4.1% | 7.8% | 18.6% | 15.6% |
| EPS Diluted | 0.75 | 1.07 | 1.85 | 1.44 |
| % Growth | -29.9% | -42.2% | 28.5% | – |
| Operating Cash Flow | $520,638 | $243,499 | $178,468 | $276,274 |
| Capital Expenditures | -$115,429 | -$78,274 | -$74,047 | -$56,898 |
| Free Cash Flow | $405,209 | $165,225 | $104,421 | $219,376 |